News AZ sells beta-blocker rights to Recordati for $300m AstraZeneca has struck a deal with Recordati, granting the Italian pharma European rights to an old beta-blocker for $300 million.
News Speech analysis tech for ALS gets FDA breakthrough tag Software that can be used to monitor patients with neurodegenerative disorder amyotrophic lateral sclerosis (ALS) using their voice patterns has been granted breakthrough
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
